The phase I study clearly showed the low toxicity of the method and the accumulation of the MMS in the target area.
i期临床研究清楚地显示，此种治疗方法是低毒性的，而且MMS能在靶区内积聚。
Yang JCH, et al. Osimertinib activity in patients (pts) with leptomeningeal (LM) disease from non-small cell lung cancer (NSCLC): updated results from BLOOM, a Phase I study.
osimertinib在非小细胞肺癌（NSCLC）所致软脑脊膜（LM）病患者（pts）中的活性：BLOOMI期研究的更新结果。
The Ad5-TRAIL gene therapy for prostate cancer research trial is a Phase I study designed to test the optimal dosage at which the therapeutic agent can safely be given to patients.
前列腺癌的Ad5-TRAIL基因疗法处于一期临床实验阶段，目的是为了得到病人安全用药的合适药物剂量。
The Ad5-TRAIL gene therapy for prostate cancer research trial is a Phase I study designed to test the optimal dosage at which the therapeutic agent can safely be given to patients.
前列腺癌的Ad5-TRAIL基因疗法处于一期临床实验阶段，目的是为了得到病人安全用药的合适药物剂量。
应用推荐